buparvaquone has been researched along with Toxoplasmosis, Cerebral in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel Shafi, IR; Abdel-Aal, AA; Afife, AA; Esmat, M; Fahmy, MEA; Hassan, SI; Shaheen, HAA; Shalaby, MA | 1 |
1 other study(ies) available for buparvaquone and Toxoplasmosis, Cerebral
| Article | Year |
|---|---|
The superior efficacy of chloroquine over buparvaquone in reducing the chronic cerebral Toxoplasma gondii cysts load and improving the ultrastructural pathology in an immunocompromised murine model.
Topics: Animals; Chloroquine; Cysts; Disease Models, Animal; Mice; Spiramycin; Toxoplasma; Toxoplasmosis, Animal; Toxoplasmosis, Cerebral | 2023 |